Malaria is the most prevalent blood-borne infectious disease caused by parasites of the species Plasmodium. In 2016, more than 216 million malaria infections were reported resulting in 445,000 deaths across the developing world.
During the blood stage development, Plasmodium (P.) falciparum, the most common causative agent of malaria-associated pathology in humans, exports a number of parasitic proteins to the surface of infected red blood cells facilitating its cyto-adhesion to endothelial receptors. This adhesive behavior prevents splenic clearance and induces microvasculature obstruction, forming critical contributors towards the disease outcome.
In a recent study, a research team from Singapore demonstrated how the adhesion of plasmodium-infected blood cells is elevated at febrile temperatures. Through dual-micropipette step-pressure technique between P. falciparum-infected RBCs (iRBCs) and Chinese Hamster Ovary cells expressing Chondroitin sulfate A (CHO-CSA), they determined that adhesion is elevated at febrile temperatures. The team also noticed that exposures to febrile temperature significantly increased both the adhesion force and adhesion percentage between iRBCs and CSA-CHO cells.
Using flow cytometry analysis, the team documented an increase in phosphatidylserine expression on the iRBC surface following exposure to febrile temperature. They demonstrate that elevated levels of phosphatidylserine is linked to increased cyto-adhesion, since the trend was reversed by introducing soluble Annexin V. "These results suggest that elevated PS recruitment on iRBC under thermally stressed conditions contributes to the increased adhesive behavior of iRBCs, which might be relevant to clinical manifestations associated with malaria fever," said Dr. Rajesh Chandramohanadas from the Singapore University of Technology & Design (SUTD).
First author of this study, published in the science journal Scientific Reports, is Dr Rou Zhang from the Infectious Disease IRG, Singapore-MIT Alliance for Research and Technology (SMART) Centre. Other investigators involved in this project are Professor Ming Dao (SMART and Massachusetts Institute of Technology), Professor Chwee Teck Lim (SMART & National University of Singapore) and Dr Rajesh Chandramohanadas (SMART and Singapore University of Technology & Design).
Source: Singapore University of Technology & Design
APIC Salutes 2025 Trailblazers in Infection Prevention and Control
June 18th 2025From a lifelong mentor to a rising star, the Association for Professionals in Infection Control and Epidemiology (APIC) honored leaders across the career spectrum at its 2025 Annual Conference in Phoenix, recognizing individuals who enhance patient safety through research, leadership, and daily practice.
Building Infection Prevention Capacity in the Middle East: A 7-Year Certification Success Story
June 17th 2025Despite rapid development, the Middle East faces a critical shortage of certified infection preventionists. A 7-year regional initiative has significantly boosted infection control capacity, increasing the number of certified professionals and elevating patient safety standards across health care settings.
Streamlined IFU Access Boosts Infection Control and Staff Efficiency
June 17th 2025A hospital-wide quality improvement project has transformed how staff access critical manufacturer instructions for use (IFUs), improving infection prevention compliance and saving time through a standardized, user-friendly digital system supported by unit-based training and interdepartmental collaboration.
Swift Isolation Protocol Shields Chicago Children’s Hospital During 2024 Measles Surge
June 17th 2025When Chicago logged its first measles cases linked to crowded migrant shelters last spring, one pediatric hospital moved in hours—not days—to prevent the virus from crossing its threshold. Their playbook offers a ready template for the next communicable-disease crisis.
Back to Basics: Hospital Restores Catheter-Associated UTI Rates to Prepandemic Baseline
June 16th 2025A 758-bed quaternary medical center slashed catheter-associated urinary tract infections (CAUTIs) by 45% over 2 years, proving that disciplined adherence to fundamental prevention steps, not expensive add-ons, can reverse the pandemic-era spike in device-related harm.